HR. 1143In Committee
Medicare IVIG Access Enhancement Act of 2025
Extends Medicare coverage to in home intravenous immune globulin administration for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy treatment
Plain-English overview
What this bill does
Extends Medicare coverage to in home intravenous immune globulin administration for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy treatment
Key points
- Extend Medicare coverage
Current status
Where it stands
Status
In Committee
Latest action
2025-02-07 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related context
Topics and policy areas
undefinedDrug therapyHealthHealth care costs and insuranceHealth care coverage and accessMedicareNeurological disorders